META and Xellera Forge Strategic Collaboration to Establish an AI + Organ-on-a-Chip Integrated R&D System
Recently, META and Shanghai Xellera Technology Co., Ltd. ("Xellera") officially signed a strategic cooperation framework agreement. The two parties will collaborate deeply in areas including humanized organ-on-a-chip, immunometabolism mechanism research, and AI-driven drug screening, aiming to upgrade the preclinical evaluation system for autoimmune disease drug discovery and build a next-generation translational medicine and drug R&D technology system.
